These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

887 related articles for article (PubMed ID: 22183981)

  • 21. Emerging paradigms for the initiation of mucin-type protein O-glycosylation by the polypeptide GalNAc transferase family of glycosyltransferases.
    Gerken TA; Jamison O; Perrine CL; Collette JC; Moinova H; Ravi L; Markowitz SD; Shen W; Patel H; Tabak LA
    J Biol Chem; 2011 Apr; 286(16):14493-507. PubMed ID: 21349845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 3 and reduced O-glycosylation in colon carcinoma cells selected for hepatic metastasis.
    Kato K; Takeuchi H; Kanoh A; Miyahara N; Nemoto-Sasaki Y; Morimoto-Tomita M; Matsubara A; Ohashi Y; Waki M; Usami K; Mandel U; Clausen H; Higashi N; Irimura T
    Glycoconj J; 2010 Feb; 27(2):267-76. PubMed ID: 20077002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycopeptide-preferring polypeptide GalNAc transferase 10 (ppGalNAc T10), involved in mucin-type O-glycosylation, has a unique GalNAc-O-Ser/Thr-binding site in its catalytic domain not found in ppGalNAc T1 or T2.
    Perrine CL; Ganguli A; Wu P; Bertozzi CR; Fritz TA; Raman J; Tabak LA; Gerken TA
    J Biol Chem; 2009 Jul; 284(30):20387-97. PubMed ID: 19460755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lectin domains of polypeptide GalNAc transferases exhibit glycopeptide binding specificity.
    Pedersen JW; Bennett EP; Schjoldager KT; Meldal M; Holmér AP; Blixt O; Cló E; Levery SB; Clausen H; Wandall HH
    J Biol Chem; 2011 Sep; 286(37):32684-96. PubMed ID: 21768105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetic modeling confirms the biosynthesis of mucin core 1 (beta-Gal(1-3) alpha-GalNAc-O-Ser/Thr) O-glycan structures are modulated by neighboring glycosylation effects.
    Gerken TA
    Biochemistry; 2004 Apr; 43(14):4137-42. PubMed ID: 15065856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting host O-linked glycan biosynthesis affects Ebola virus replication efficiency and reveals differential GalNAc-T acceptor site preferences on the Ebola virus glycoprotein.
    Bagdonaite I; Abdurahman S; Mirandola M; Pasqual D; Frank M; Narimatsu Y; Joshi HJ; Vakhrushev SY; Salata C; Mirazimi A; Wandall HH
    J Virol; 2024 Jun; 98(6):e0052424. PubMed ID: 38757972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of the site-specific O-glycosylation pattern of the porcine submaxillary mucin tandem repeat glycopeptide. Model proposed for the polypeptide:galnac transferase peptide binding site.
    Gerken TA; Owens CL; Pasumarthy M
    J Biol Chem; 1997 Apr; 272(15):9709-19. PubMed ID: 9092502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. UDP-N-acetyl-α-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase from the snail Biomphalaria glabrata - structural reflections.
    Turupcu A; Poliak P; Margreitter C; Oostenbrink C; Staudacher E
    Glycoconj J; 2020 Feb; 37(1):15-25. PubMed ID: 31396754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The acceptor substrate specificity of porcine submaxillary UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase is dependent on the amino acid sequences adjacent to serine and threonine residues.
    Wang Y; Agrwal N; Eckhardt AE; Stevens RD; Hill RL
    J Biol Chem; 1993 Nov; 268(31):22979-83. PubMed ID: 8226812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GALNTs: master regulators of metastasis-associated epithelial-mesenchymal transition (EMT)?
    Beaman EM; Carter DRF; Brooks SA
    Glycobiology; 2022 Jun; 32(7):556-579. PubMed ID: 35312770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An unusual dual sugar-binding lectin domain controls the substrate specificity of a mucin-type O-glycosyltransferase.
    Collette AM; Hassan SA; Schmidt SI; Lara AJ; Yang W; Samara NL
    Sci Adv; 2024 Mar; 10(9):eadj8829. PubMed ID: 38416819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diverse glycosylation of MUC1 and MUC2: potential significance in tumor immunity.
    Irimura T; Denda K; Iida Si; Takeuchi H; Kato K
    J Biochem; 1999 Dec; 126(6):975-85. PubMed ID: 10578046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specificity of O-glycosylation by bovine colostrum UDP-GalNAc: polypeptide alpha-N-acetylgalactosaminyltransferase using synthetic glycopeptide substrates.
    Brockhausen I; Toki D; Brockhausen J; Peters S; Bielfeldt T; Kleen A; Paulsen H; Meldal M; Hagen F; Tabak LA
    Glycoconj J; 1996 Oct; 13(5):849-56. PubMed ID: 8910012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High level in vivo mucin-type glycosylation in Escherichia coli.
    Mueller P; Gauttam R; Raab N; Handrick R; Wahl C; Leptihn S; Zorn M; Kussmaul M; Scheffold M; Eikmanns B; Elling L; Gaisser S
    Microb Cell Fact; 2018 Oct; 17(1):168. PubMed ID: 30367634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The interdomain flexible linker of the polypeptide GalNAc transferases dictates their long-range glycosylation preferences.
    de Las Rivas M; Lira-Navarrete E; Daniel EJP; Compañón I; Coelho H; Diniz A; Jiménez-Barbero J; Peregrina JM; Clausen H; Corzana F; Marcelo F; Jiménez-Osés G; Gerken TA; Hurtado-Guerrero R
    Nat Commun; 2017 Dec; 8(1):1959. PubMed ID: 29208955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The lectin domain of UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-T4 directs its glycopeptide specificities.
    Hassan H; Reis CA; Bennett EP; Mirgorodskaya E; Roepstorff P; Hollingsworth MA; Burchell J; Taylor-Papadimitriou J; Clausen H
    J Biol Chem; 2000 Dec; 275(49):38197-205. PubMed ID: 10984485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of sequon engineering for improved O-glycosylation by the human polypeptide N-acetylgalactosaminyl transferase T2 isozyme and two orthologues.
    Thompson NK; LeClaire LTN; Rodriguez Perez S; Wakarchuk WW
    Biochem J; 2021 Oct; 478(19):3527-3537. PubMed ID: 34523671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of two cysteine residues involved in the binding of UDP-GalNAc to UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 1 (GalNAc-T1).
    Tenno M; Toba S; Kézdy FJ; Elhammer AP; Kurosaka A
    Eur J Biochem; 2002 Sep; 269(17):4308-16. PubMed ID: 12199709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cloning and characterization of a new human UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase, designated pp-GalNAc-T13, that is specifically expressed in neurons and synthesizes GalNAc alpha-serine/threonine antigen.
    Zhang Y; Iwasaki H; Wang H; Kudo T; Kalka TB; Hennet T; Kubota T; Cheng L; Inaba N; Gotoh M; Togayachi A; Guo J; Hisatomi H; Nakajima K; Nishihara S; Nakamura M; Marth JD; Narimatsu H
    J Biol Chem; 2003 Jan; 278(1):573-84. PubMed ID: 12407114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural Analysis of a GalNAc-T2 Mutant Reveals an Induced-Fit Catalytic Mechanism for GalNAc-Ts.
    de Las Rivas M; Coelho H; Diniz A; Lira-Navarrete E; Compañón I; Jiménez-Barbero J; Schjoldager KT; Bennett EP; Vakhrushev SY; Clausen H; Corzana F; Marcelo F; Hurtado-Guerrero R
    Chemistry; 2018 Jun; 24(33):8382-8392. PubMed ID: 29601100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.